<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-35481" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Axenfeld-Rieger Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zamora</surname>
            <given-names>Edgar A.</given-names>
          </name>
          <aff>Montefiore Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salini</surname>
            <given-names>Baby</given-names>
          </name>
          <aff>Ahalia Foundation Eye Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Edgar Zamora declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Baby Salini declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-35481.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Axenfeld-Rieger syndrome (ARS) is a disease that encompasses anterior segment ocular dysgenesis in addition to systemic abnormalities such as dental, cardiac, craniofacial, and abdominal wall defects. Previously, this syndrome was separated into multiple entities, including Axenfeld anomaly, Rieger anomaly, and Rieger syndrome. Axenfeld anomaly has been characterized by posterior embryotoxon and peripheral iris strand attachment. Rieger anomaly denoted posterior embryotoxon, iris hypoplasia, polycoria, and corectopia. Association of systemic findings with Rieger anomaly, including dental abnormalities, changes of the facial bones such as maxillary hypoplasia, umbilical abnormalities (redundant periumbilical skin), hypospadias, and pituitary abnormalities, has been called Rieger syndrome. However, it has been recognized that all these previous entities fall under a group of diseases, which is now called ARS. This activity reviews the presentation of ARS and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify individuals with suspected Axenfeld-Rieger syndrome based on clinical signs and symptoms, such as ocular abnormalities, dental malformations, and maxillary hypoplasia.</p></list-item><list-item><p>Implement appropriate treatment and management strategies for patients with Axenfeld-Rieger Syndrome, which may include regular monitoring of intraocular pressure, early detection and management of glaucoma, and referral to relevant specialists.</p></list-item><list-item><p>Apply evidence-based treatment approaches for managing specific complications associated with Axenfeld-Rieger syndrome, tailoring interventions to individual patient needs and characteristics.</p></list-item><list-item><p>Collaborate with other healthcare professionals, including ophthalmologists, geneticists, and dentists, to develop comprehensive management plans and ensure coordinated care for individuals with Axenfeld-Rieger Syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35481&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35481">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-35481.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>In 920, the German ophthalmologist Theodor Axenfeld made an important contribution to the field by&#x000a0;describing a prominent and anteriorly displaced Schwalbe line (posterior embryotoxon) with the adhesion of peripheral iris strands.<xref ref-type="bibr" rid="article-35481.r1">[1]</xref>&#x000a0;Later, these&#x000a0;observations&#x000a0;became known as the Axenfeld anomaly.<xref ref-type="bibr" rid="article-35481.r2">[2]</xref>&#x000a0;Another significant advancement came from the Austrian ophthalmologist Herwigh Rieger, who described a distinct set of ocular abnormalities known as the "Rieger anomaly."&#x000a0;This anomaly&#x000a0;encompasses&#x000a0;posterior embryotoxon, iris hypoplasia, polycoria, and corectopia.<xref ref-type="bibr" rid="article-35481.r3">[3]</xref><xref ref-type="bibr" rid="article-35481.r4">[4]</xref>&#x000a0;</p>
        <p>The&#x000a0;constellation of systemic findings&#x000a0;in conjunction with Rieger anomaly,&#x000a0;such as dental abnormalities, facial bone changes, umbilical abnormalities, hypospadias, and pituitary abnormalities, was called Rieger syndrome.<xref ref-type="bibr" rid="article-35481.r1">[1]</xref><xref ref-type="bibr" rid="article-35481.r2">[2]</xref><xref ref-type="bibr" rid="article-35481.r5">[5]</xref>&#x000a0;In current medical terminology,&#x000a0;the&#x000a0;terms Axenfeld anomaly, Rieger anomaly, and Rieger syndrome are no longer used.&#x000a0;Instead, these ocular findings and associated systemic manifestations are now recognized under a spectrum of disorders called Axenfeld-Riger syndrome (ARS).<xref ref-type="bibr" rid="article-35481.r6">[6]</xref>&#x000a0;</p>
        <p>ARS is a disease that encompasses anterior segment ocular dysgenesis and systemic abnormalities such as dental, cardiac, craniofacial, and abdominal wall defects. The mutations associated with ARS include PITX2 (chromosome 4q25), FOXC1 (chromosome 6p25), PAX6 (chromosome 11p13), FOXO1A&#x000a0;(chromosome 13q14), and CYP1B1 (chromosome 2p22.2).<xref ref-type="bibr" rid="article-35481.r2">[2]</xref><xref ref-type="bibr" rid="article-35481.r7">[7]</xref><xref ref-type="bibr" rid="article-35481.r8">[8]</xref><xref ref-type="bibr" rid="article-35481.r9">[9]</xref></p>
      </sec>
      <sec id="article-35481.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>ARS is associated with various chromosome mutations, including mutations in chromosomes 2, 4, 6, 9, 13, 18, and 21.</p>
        <p>ARS type 1 (RIEG 1, OMIM&#x000a0;#180500) is an autosomal dominant (AD) disorder caused by a heterozygous mutation in the PITX2 gene&#x000a0;located on chromosome 4q25. The PITX2 gene is a&#x000a0;homeobox transcription factor crucial&#x000a0;in developing&#x000a0;teeth and the iris.</p>
        <p>ARS type 2 (RIEG 2, OMIM %601499) is an autosomal dominant (AD) disorder linked to chromosome 13q14. In the OMIM nomenclature, the "%" sign denotes that the phenotype description or locus is known, but the molecular basis is yet to be identified.</p>
        <p>ARS type 3 (RIEG 3, OMIM # 602482) is an autosomal dominant (AD) disorder linked to chromosome 6p25.3, specifically involving the FOXC1 gene. Heterozygous mutations in the FOXC1 gene are known to cause ARS type 3.&#x000a0;Chromosome 6pter-p24 deletion syndrome (OMIM&#x000a0;#&#x000a0;612582)&#x000a0;is a contiguous gene deletion syndrome&#x000a0;that shares&#x000a0;phenotypic&#x000a0;similarities with&#x000a0;ARS type 3. The FOXC1 gene, also known as forkhead box 1, has been referred to as&#x000a0;forkhead, drosophila, homolog-like 7 (FKHL7), and&#x000a0;forkhead-related activator 3 (FREAC3).<xref ref-type="bibr" rid="article-35481.r10">[10]</xref>&#x000a0;</p>
        <p>Approximately 25% to 30% of cases with ocular features suggestive of ARS correlate with mutations in FOXC1 and PITX2 on chromosomes 6p25 and 4q25, respectively.<xref ref-type="bibr" rid="article-35481.r11">[11]</xref>&#x000a0;Forkhead-Box C1 gene (FOXC1) and the Pituitary Homeobox 2 gene (PITX2) are the most studied transcription factor-encoding genes associated with ARS. Research has characterized FOXC1 mutations as frameshift, nonsense, missense, deletions, and duplications. PITX2 has been related to splice-site mutations, omissions, and chromosomal translocations in patients with ARS.<xref ref-type="bibr" rid="article-35481.r11">[11]</xref>&#x000a0;</p>
        <p>Approximately 10% to 30% of patients with ARS present PITX2 mutations in 4q25.<xref ref-type="bibr" rid="article-35481.r1">[1]</xref><xref ref-type="bibr" rid="article-35481.r12">[12]</xref><xref ref-type="bibr" rid="article-35481.r13">[13]</xref>&#x000a0;Animal models have shown that ocular structures affected in ARS express FOXC1 and PITX2.<xref ref-type="bibr" rid="article-35481.r7">[7]</xref><xref ref-type="bibr" rid="article-35481.r14">[14]</xref>&#x000a0;A distinct phenotype of ARS, referred to as De Hauwere Syndrome (OMIM 109120), has been&#x000a0;characterized by the presence of&#x000a0;hydrocephalus, partially absent eye muscles, hypertelorism, lax joints, psychomotor retardation, and sensorineural deafness.<xref ref-type="bibr" rid="article-35481.r15">[15]</xref><xref ref-type="bibr" rid="article-35481.r16">[16]</xref></p>
        <p>Genetic heterogeneity in conditions like ARS means that various genes can lead to similar features or phenotypes. The inheritance pattern of most cases of ARS&#x000a0;is autosomal dominant,&#x000a0;although sporadic cases also arise. ARS is typically characterized by high penetrance&#x000a0;but exhibits variable expressivity.</p>
      </sec>
      <sec id="article-35481.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of ARS is estimated&#x000a0;to be around&#x000a0;1 in 50,000 to 100,000 to&#x000a0;1 in 200,000 live births.<xref ref-type="bibr" rid="article-35481.r2">[2]</xref><xref ref-type="bibr" rid="article-35481.r17">[17]</xref>&#x000a0;There is no racial or gender preference. In most cases, both eyes are affected by the characteristic features of ARS.</p>
      </sec>
      <sec id="article-35481.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Axenfeld-Rieger syndrome is believed to be caused by abnormal neural crest (NC) migration during early embryogenesis. Important ocular structures such as the ciliary body, cornea, and iris stroma rely on adequate NC cell migration. Transcription factors in different genes strongly regulate these processes.<xref ref-type="bibr" rid="article-35481.r18">[18]</xref><xref ref-type="bibr" rid="article-35481.r19">[19]</xref>&#x000a0;</p>
        <p>During late gestation,&#x000a0;the primordial endothelium that covers the cornea is expected to&#x000a0;undergo resorption; disruption in&#x000a0;this process may result in the development of posterior embryotoxon and abnormal insertion of the iris, causing pupillary changes such as pseudopolycoria or ectropion uveae.<xref ref-type="bibr" rid="article-35481.r18">[18]</xref><xref ref-type="bibr" rid="article-35481.r19">[19]</xref>&#x000a0;The previously discussed abnormalities in the development of the anterior chamber&#x000a0;may&#x000a0;affect the development of the Schlemm canal, impairing the outflow of aqueous humor and increasing the risk of glaucoma.<xref ref-type="bibr" rid="article-35481.r18">[18]</xref><xref ref-type="bibr" rid="article-35481.r19">[19]</xref>&#x000a0;</p>
        <p>Abnormal NC migration associated with ARS often affects extraocular tissues, such as vestibuloacoustic ganglion tissue, which may cause hearing loss in some patients with ARS.<xref ref-type="bibr" rid="article-35481.r18">[18]</xref><xref ref-type="bibr" rid="article-35481.r19">[19]</xref>&#x000a0;The pathogenesis of ARS involves abnormalities in the differentiation, development, or migration of neural crest cells, contributing to the ocular and systemic features observed in affected individuals. The third wave of neural crest gives rise to the iris stroma.<xref ref-type="bibr" rid="article-35481.r20">[20]</xref>&#x000a0;Research suggests abnormalities or disturbances in the third wave of neural crest cell&#x000a0;migration can result in ARS.<xref ref-type="bibr" rid="article-35481.r21">[21]</xref>&#x000a0;It is proposed that the developmental arrest of the tissues derived from neural crest cells in late gestation leads to the retention of the primordial endothelium over the iris and the angle of the anterior chamber.<xref ref-type="bibr" rid="article-35481.r6">[6]</xref>&#x000a0;This abnormal tissue continues to contract, resulting in some of the progressive changes seen in patients with ARS.<xref ref-type="bibr" rid="article-35481.r6">[6]</xref></p>
      </sec>
      <sec id="article-35481.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The widely accepted definition of posterior embryotoxon is an anteriorly displaced and visibly prominent Schwalbe line. However, an immunohistopathological study revealed&#x000a0;that in some cases, posterior embryotoxon is a direct extension of the corneal stroma ('peripheral corneal stromal nub') lined by the Descemet membrane.<xref ref-type="bibr" rid="article-35481.r22">[22]</xref>&#x000a0;This study noted that&#x000a0;the locations of these nubs were anterior, posteriorly, at the Schwalbe line, or partially embedded in the trabecular meshwork.<xref ref-type="bibr" rid="article-35481.r22">[22]</xref>&#x000a0;</p>
        <p>The histology of ARS shows features of abnormal anterior segment cleavage, including prominent Schwalbe line, hypoplasia of Schlemm canal and iris, hypocellular trabecular meshwork, and iridocorneal adhesion.<xref ref-type="bibr" rid="article-35481.r23">[23]</xref>&#x000a0;The histopathological features of ARS and iridocorneal endothelial syndrome can be similar and characterized by a Descement-like membrane and endothelial-like cells.<xref ref-type="bibr" rid="article-35481.r24">[24]</xref> These extend from the cornea to the iris's anterior surface and the anterior chamber's angle. These changes are typically located toward the side of pupillary displacement or ectropion uveae and at the opposite quadrant of the atrophic disrupted iris.<xref ref-type="bibr" rid="article-35481.r24">[24]</xref></p>
      </sec>
      <sec id="article-35481.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Axenfeld-Rieger syndrome commonly correlates with ocular, dental, facial, and abdominal abnormalities.<xref ref-type="bibr" rid="article-35481.r8">[8]</xref><xref ref-type="bibr" rid="article-35481.r25">[25]</xref>&#x000a0;ARS is the preferred term for discussing this group of phenotypically similar disorders, which was historically divided into different entities, including&#x000a0;Axenfeld anomaly, Rieger anomaly, and Rieger syndrome. The majority of ARS cases are diagnosed during&#x000a0;infancy or&#x000a0;childhood. Glaucoma&#x000a0;is usually detected during&#x000a0;middle to late childhood or even in adulthood. However, congenital or early-onset glaucoma (diagnosis within 3 years of age) may occur.<xref ref-type="bibr" rid="article-35481.r26">[26]</xref>&#x000a0;</p>
        <p>Congenital glaucoma presents with a large bluish cornea (buphthalmos), watering, and photophobia.&#x000a0;The usual presenting complaints include an abnormal eye appearance, squint, or dimness of vision. Photophobia is common and is caused by abnormalities of the iris and the pupil. Many cases are detected on routine ocular examination. All patients must receive a comprehensive ophthalmic examination.</p>
        <p>Posterior embryotoxon is characterized by a prominent and anteriorly displaced Schwalbe line visible in the slit-lamp without gonioscopy. Peripheral iris strands are attached to this posterior embryotoxon, better visualized with gonioscopy. The prominent Schwalbe line may be missed in the slit-lamp examination if the gonioscopy is not done. Intraocular pressure should also be checked.</p>
        <p>The historical term 'Axenfeld anomaly' included a prominent and anteriorly displaced Schwalbe line on evaluation. It is also necessary to recognize that posterior embryotoxon can be observed in various conditions, including Alagille syndrome, and can also be present&#x000a0;in individuals without any underlying health issues. Posterior embryotoxon is incidentally found in approximately&#x000a0;8% to 15% of normal individuals. This finding often occurs without any ocular or systemic abnormalities, including glaucoma.<xref ref-type="bibr" rid="article-35481.r27">[27]</xref><xref ref-type="bibr" rid="article-35481.r28">[28]</xref></p>
        <p>Iris abnormalities associated with ARS include stromal hypoplasia, full-thickness iris defects (iris holes) that can give rise to the appearance of multiple pupils (pseudo polycoria), a decentered pupil (corectopia), and ectropion uveae. Typically, the cornea is clear, contrary to the iridocorneal endothelial (ICE) syndrome. The previous name for these findings and posterior embryotoxon was Rieger anomaly. These features may be clinically very similar to ICE syndrome, which is usually unilateral and seen in older age groups. The iris&#x000a0;may be normal in some cases. Other ocular findings include anterior&#x000a0;peripheral anterior synechiae, corneal opacity, megalocornea, microcornea, and glaucoma.</p>
        <p>The association of Rieger anomaly with&#x000a0;extraocular&#x000a0;conditions was previously called Rieger syndrome. An abnormality in the neural crest cell-related tissue development also causes these. Tooth-related abnormalities commonly observed include hypodontia (absence of 1-5 teeth), oligodontia (absence of &#x02265; 6 teeth),&#x000a0;and microdontia (small-sized teeth). Facial&#x000a0;features include mild craniofacial dysmorphism, telecanthus, hypertelorism, maxillary hypoplasia, and broad flat nasal bridge. Other systemic associations include hypospadias, redundant periumbilical skin, umbilical hernia, hydrocephalus, deafness, anal stenosis, renal anomalies, cardiac (valvular) abnormalities, arachnoid cyst,<xref ref-type="bibr" rid="article-35481.r29">[29]</xref> pituitary (empty sella) abnormalities<xref ref-type="bibr" rid="article-35481.r19">[19]</xref>, endocrine abnormalities (short stature, growth retardation), and congenital hip dislocation.</p>
      </sec>
      <sec id="article-35481.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Gonioscopy is an essential component of the evaluation process for&#x000a0;individuals&#x000a0;with ARS, as it allows for a detailed examination of the iridocorneal angle. Commonly observed features of ARS when performing gonioscopy include a prominent Schwalbe line, iris strands attached to the Schwalbe line, anterior insertion of the iris, and the presence of iris processes. The iris strands attached to the cornea can be delicate or broad.</p>
        <p>In addition to gonioscopy, other ocular investigations for ARS include anterior segment photography, goniophotography, fundus (optic disc) photography, corneal pachymetry, optical coherence tomography of peripapillary retinal nerve fiber layer and macular ganglion cell complex, and Humphrey visual fields.<xref ref-type="bibr" rid="article-35481.r30">[30]</xref></p>
        <p>Evaluation for patients with 6p25 microdeletion syndrome should be comprehensive and include a referral to an ophthalmologist, particularly for patients with posterior embryotoxon. Other studies should consist of neurodevelopmental evaluation, screening echocardiogram, brain imaging, hearing and vision tests, and auditory brainstem response evaluation.<xref ref-type="bibr" rid="article-35481.r31">[31]</xref></p>
        <p>Childhood glaucoma is a common complication in ARS. Patients with ARS should undergo prompt evaluation and appropriate treatment to preserve their vision. In cases of congenital glaucoma, a comprehensive examination under anesthesia is often necessary to assess&#x000a0;various parameters, including corneal diameter, intraocular pressure, optic nerve head status, and&#x000a0;axial length measurement. While primary care providers may detect the clinical symptoms and initially diagnose, these patients will require further evaluation by specialists as they may eventually require surgical interventions or specialized care to prevent permanent disabilities or blindness.<xref ref-type="bibr" rid="article-35481.r26">[26]</xref><xref ref-type="bibr" rid="article-35481.r32">[32]</xref></p>
      </sec>
      <sec id="article-35481.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is individualized as the clinical presentation of patients with Axenfeld-Rieger syndrome is highly variable. Approximately half of the patients will develop glaucoma, which may eventually require surgical procedures such as trabeculectomy and trabeculotomy. These therapies have effectively controlled intraocular pressure, as described in a retrospective analysis of 24 children diagnosed with ARS and early-onset glaucoma.<xref ref-type="bibr" rid="article-35481.r26">[26]</xref><xref ref-type="bibr" rid="article-35481.r32">[32]</xref></p>
        <p>Medical management of glaucoma associated with ARS is usually ineffective in most cases. A study found that out of 46 eyes with ARS-related glaucoma, 31 (67%) needed surgery for glaucoma.<xref ref-type="bibr" rid="article-35481.r33">[33]</xref> The options for medical management include beta-blockers, carbonic anhydrase inhibitors,&#x000a0;and&#x000a0;prostaglandin analogs. Alpha agonists, including&#x000a0;brimonidine, can cause sleep&#x000a0;apnea and central nervous system depression in children, which&#x000a0;must be avoided in individuals&#x000a0;younger than 2 years.</p>
        <p>Goniotomy and trabeculotomy procedures may have low effectiveness in the long term as angle dysgenesis and other developmental abnormalities may be present.<xref ref-type="bibr" rid="article-35481.r33">[33]</xref>&#x000a0;In such cases, surgical options are more effective. These include trabeculectomy with anti-fibrotics, including mitomycin&#x000a0;c,<xref ref-type="bibr" rid="article-35481.r33">[33]</xref>&#x000a0;combined trabeculotomy and trabeculectomy,<xref ref-type="bibr" rid="article-35481.r26">[26]</xref> and glaucoma drainage devices.<xref ref-type="bibr" rid="article-35481.r34">[34]</xref> However, most of these cases require&#x000a0;more than one surgery, and maintaining the intraocular pressure (IOP) long-term is difficult in many cases, even with medical and surgical management.&#x000a0;</p>
        <p>Some patients may need cycloablative&#x000a0;procedures, including cyclocryotherapy and diode laser cyclophotocoagulation. The risk of surgery may vary and includes hypotony, suprachoroidal hemorrhage, and endophthalmitis. A thorough risk-benefit analysis should be performed before planning an intervention for such cases.</p>
      </sec>
      <sec id="article-35481.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Iridocorneal Endothelial Syndrome</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>More commonly observed in middle&#x000a0;age females</p>
          </list-item>
          <list-item>
            <p>Often affects one eye asymmetrically</p>
          </list-item>
          <list-item>
            <p>Presence of an abnormal&#x000a0;corneal endothelium</p>
          </list-item>
          <list-item>
            <p>Three variants:
<list list-type="bullet"><list-item><p>Chandler Syndrome: Abnormal behavior of the corneal endothelium, which takes on epithelial-like characteristics. This abnormality results in distinct features, such as&#x000a0;a beaten bronze appearance of the corneal endothelium and subsequent corneal edema.</p></list-item><list-item><p>Essential iris atrophy: Progressive iris atrophy resulting in the formation of iris holes, pseudopolycoria, and corectopia.</p></list-item><list-item><p>Cogan-Reese (iris nevus): Iris nodules at the anterior surface of the iris.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>&#x000a0;Iridoschisis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>There is a splitting of iris layers.<xref ref-type="bibr" rid="article-35481.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Usually, pigmented iris epithelium on the posterior surface of the iris remains intact.</p>
          </list-item>
          <list-item>
            <p>The inferior iris is generally involved.</p>
          </list-item>
          <list-item>
            <p>Associated with the shallow anterior chamber and angle closure glaucoma.</p>
          </list-item>
        </list>
        <p>
<bold>Peters Anomaly</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Congenital central corneal opacity with or without iris adhesion or cataract<xref ref-type="bibr" rid="article-35481.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Aniridia (iris hypoplasia)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Iris is absent in slit-lamp examination; however, a rudimentary iris stump is visible on careful examination or gonioscopy.<xref ref-type="bibr" rid="article-35481.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Limbal stem cell deficiency, corneal pannus</p>
          </list-item>
          <list-item>
            <p>Glaucoma</p>
          </list-item>
          <list-item>
            <p>Foveal hypoplasia</p>
          </list-item>
          <list-item>
            <p>Optic nerve head hypoplasia</p>
          </list-item>
        </list>
        <p>
<bold>Isolated Posterior Embryotoxon</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal iris and absence of glaucoma</p>
          </list-item>
        </list>
        <p>
<bold>Oculodentodigital Dysplasia (OMIM #&#x000a0;164200)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal dominant</p>
          </list-item>
          <list-item>
            <p>Due to mutations in the connexin-43 gene (GJA1) on chromosome 6q22</p>
          </list-item>
          <list-item>
            <p>Microphthalmia</p>
          </list-item>
          <list-item>
            <p>Microcornea</p>
          </list-item>
          <list-item>
            <p>Glaucoma</p>
          </list-item>
          <list-item>
            <p>Cataract</p>
          </list-item>
          <list-item>
            <p>Narrow, pinched nose</p>
          </list-item>
          <list-item>
            <p>Enamel hypoplasia and microdontia</p>
          </list-item>
          <list-item>
            <p>Syndactyly of the 4th and 5th fingers</p>
          </list-item>
        </list>
        <p>
<bold>Congenital Ectropion Uveae</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cryptless smooth anterior iris surface</p>
          </list-item>
          <list-item>
            <p>Visible pigmented epithelium at the pupillary margin and anterior surface of the iris<xref ref-type="bibr" rid="article-35481.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>High iris insertion</p>
          </list-item>
          <list-item>
            <p>Associated glaucoma</p>
          </list-item>
          <list-item>
            <p>Other causes of congenital ectropion uveae should be ruled out</p>
          </list-item>
        </list>
        <p>
<bold>Ectopia Lentis Et Pupillae</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal recessive</p>
          </list-item>
          <list-item>
            <p>Mutation of ADAMTSL4 gene&#x000a0;(chromosome 1q21)</p>
          </list-item>
          <list-item>
            <p>Both eyes involved</p>
          </list-item>
          <list-item>
            <p>Usually, inferotemporally displaced pupil (corectopia)</p>
          </list-item>
          <list-item>
            <p>Subluxation of the lens in the opposite side of pupillary displacement (usually superonasally subluxated lens)</p>
          </list-item>
          <list-item>
            <p>Myopia</p>
          </list-item>
          <list-item>
            <p>Retinal detachment</p>
          </list-item>
          <list-item>
            <p>Cataracts</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35481.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis varies individually as patients with ARS have varied clinical presentations and different degrees of comorbidities. While some patients may only present anterior ocular chamber abnormalities, others may also have cardiac defects of varying severity, which may worsen&#x000a0;their prognosis.<xref ref-type="bibr" rid="article-35481.r11">[11]</xref>&#x000a0;The ocular&#x000a0;prognosis is good in the absence of glaucoma. However, glaucoma may be challenging to treat and not respond to medical therapy alone. Patients with ARS who require&#x000a0;glaucoma surgery typically&#x000a0;undergo multiple surgeries, with an average of approximately 2.2 surgeries performed on&#x000a0;each eye.<xref ref-type="bibr" rid="article-35481.r33">[33]</xref>&#x000a0;Late diagnosis and delayed management of glaucoma can cause blindness, phthisis,&#x000a0;or painful blind eye.<xref ref-type="bibr" rid="article-35481.r39">[39]</xref></p>
      </sec>
      <sec id="article-35481.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The diseases linked to Axenfeld-Rieger syndrome can&#x000a0;be associated with various complications, including ocular abnormalities such as posterior embryotoxon. Approximately 50% of patients with ARS develop glaucoma.<xref ref-type="bibr" rid="article-35481.r11">[11]</xref>&#x000a0;While glaucoma is usually diagnosed after middle childhood, early-onset glaucoma may occur.<xref ref-type="bibr" rid="article-35481.r26">[26]</xref>&#x000a0;High&#x000a0;iris insertion is a common finding in all ARS cases, but these are more pronounced in eyes with glaucoma.<xref ref-type="bibr" rid="article-35481.r6">[6]</xref>&#x000a0;Developmental abnormalities, including peripheral iris strands, iris changes, and posterior embryotoxon, may not correlate with the presence or severity of glaucoma.<xref ref-type="bibr" rid="article-35481.r6">[6]</xref>&#x000a0;The cause of glaucoma in ARS is&#x000a0;thought to be angle&#x000a0;dysgenesis or incomplete development of the trabecular meshwork and the Schlemm canal. It is believed that an arrest of the development of neural crest cells leads&#x000a0;to the persistence of primordial endothelial cells over the angle and the iris, resulting in iridogoniodysgenesis that obstructs&#x000a0;aqueous outflow and leads to glaucoma.</p>
        <p>Congenital glaucoma (CG) in patients is often associated with FOXC1 and PITX2 gene mutations. CG may lead to severe complications, including blindness or partial vision loss in children.<xref ref-type="bibr" rid="article-35481.r40">[40]</xref>&#x000a0;Amblyopia is a relatively common complication of childhood glaucoma.<xref ref-type="bibr" rid="article-35481.r32">[32]</xref>&#x000a0;Patients with FOXC1 mutations may also present with hearing loss and ocular and heart complications.<xref ref-type="bibr" rid="article-35481.r1">[1]</xref>&#x000a0;In a study involving a&#x000a0;three-generation family with 3&#x000a0;cases of ARS and heart disease, FOXC1 mutations were detected, suggesting the involvement of this gene in cardiac development.<xref ref-type="bibr" rid="article-35481.r41">[41]</xref></p>
      </sec>
      <sec id="article-35481.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients and their families may benefit from being informed about&#x000a0;the type and risk of complications associated with the&#x000a0;spectrum of ARS, including the&#x000a0;increased risk of&#x000a0;glaucoma.<xref ref-type="bibr" rid="article-35481.r11">[11]</xref>&#x000a0;Alongside ocular abnormalities, ARS carries associations with dental malformations and maxillary hypoplasia. Referral to an orofacial specialist, such as a maxillofacial surgeon, may benefit patients experiencing these complications.<xref ref-type="bibr" rid="article-35481.r1">[1]</xref>&#x000a0;Genetic counseling and possibly testing can&#x000a0;be offered to patients as some&#x000a0;variants of ARS are inherited in an autosomal dominant fashion.<xref ref-type="bibr" rid="article-35481.r1">[1]</xref></p>
      </sec>
      <sec id="article-35481.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Some authors have described different variants or subtypes of ARS, leading to various terms such as&#x000a0;Axenfeld anomaly and Rieger anomaly, among others, being used to describe different pathological presentations. Despite these variations in terminology, all these presentations share a common phenotype. It may be beneficial to use a unified terminology encompassing all these conditions to facilitate better communication among&#x000a0;specialists involved in the care of patients with ARS, including optometrists, ophthalmologists, and ophthalmic nurses.<xref ref-type="bibr" rid="article-35481.r11">[11]</xref>&#x000a0;</p>
        <p>Managing patients with ARS requires a multidisciplinary approach involving various healthcare providers, such&#x000a0;as primary physicians, nurses, ophthalmologists of different&#x000a0;subspecialties, dentists, endocrinologists, and geneticists.</p>
      </sec>
      <sec id="article-35481.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35481&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35481">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/axenfeld-rieger-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=35481">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/35481/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=35481">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-35481.s16">
        <fig id="article-35481.image.f1" position="float" orientation="portrait">
          <caption>
            <p>The slit lamp image of the patient depicts posterior embryotoxon, moderate anterior chamber depth, correctopia, polycoria, early iris atrophy, and iris mammillations. "Contributed by Dr. Bharat Gurnani, MBBS, DNB, FCRS, FICO, MRCS Ed, MNAMS"</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Q9__SP__OCT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-35481.s17">
        <title>References</title>
        <ref id="article-35481.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The rare Axenfeld-Rieger syndrome with systemic anomalies: A case report and brief review of literature.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>96</volume>
            <issue>33</issue>
            <fpage>e7791</fpage>
            <pub-id pub-id-type="pmid">28816964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seifi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger syndrome.</article-title>
            <source>Clin Genet</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>93</volume>
            <issue>6</issue>
            <fpage>1123</fpage>
            <page-range>1123-1130</page-range>
            <pub-id pub-id-type="pmid">28972279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Dwyer</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Dental anomalies in Axenfeld-Rieger syndrome.</article-title>
            <source>Int J Paediatr Dent</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>459</fpage>
            <page-range>459-63</page-range>
            <pub-id pub-id-type="pmid">16238657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schinzel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Herwigh Rieger, 2 May 1898-1 February 1986.</article-title>
            <source>Am J Med Genet</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>749</fpage>
            <page-range>749-52</page-range>
            <pub-id pub-id-type="pmid">3321987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Padhy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sarangi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Unclassified Axenfeld-Rieger Syndrome: A CASE SERIES and Review of Literature.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2018</year>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>300</fpage>
            <page-range>300-307</page-range>
            <pub-id pub-id-type="pmid">27929720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1983</year>
            <volume>81</volume>
            <fpage>736</fpage>
            <page-range>736-84</page-range>
            <pub-id pub-id-type="pmid">6676983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Zabaleta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kume</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Savinova</surname>
                <given-names>OV</given-names>
              </name>
              <name>
                <surname>Kidson</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Alward</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development.</article-title>
            <source>Hum Mol Genet</source>
            <year>2000</year>
            <month>Apr</month>
            <day>12</day>
            <volume>9</volume>
            <issue>7</issue>
            <fpage>1021</fpage>
            <page-range>1021-32</page-range>
            <pub-id pub-id-type="pmid">10767326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Swiderski</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Alward</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Searby</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bennet</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kanis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Gastier</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Sheffield</surname>
                <given-names>VC</given-names>
              </name>
            </person-group>
            <article-title>The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25.</article-title>
            <source>Nat Genet</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-7</page-range>
            <pub-id pub-id-type="pmid">9620769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanwar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dada</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger Syndrome Associated with Congenital Glaucoma and Cytochrome P4501B1 Gene Mutations.</article-title>
            <source>Case Rep Med</source>
            <year>2010</year>
            <volume>2010</volume>
            <pub-id pub-id-type="pmid">20827438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mears</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mirzayans</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kume</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Parlee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Koop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Carlsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Enerb&#x000e4;ck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morissette</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly.</article-title>
            <source>Am J Hum Genet</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>1316</fpage>
            <page-range>1316-28</page-range>
            <pub-id pub-id-type="pmid">9792859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alward</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger syndrome in the age of molecular genetics.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>130</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-15</page-range>
            <pub-id pub-id-type="pmid">11004268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirzayans</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>H&#x000e9;on</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Billingsley</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mears</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger syndrome resulting from mutation of the FKHL7 gene on chromosome 6p25.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-4</page-range>
            <pub-id pub-id-type="pmid">10713890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vos</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Stegmann</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Webers</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Stumpel</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>The 6p25 deletion syndrome: An update on a rare neurocristopathy.</article-title>
            <source>Ophthalmic Genet</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-107</page-range>
            <pub-id pub-id-type="pmid">27070436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berry</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Lines</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Oas</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Footz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Underhill</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis.</article-title>
            <source>Hum Mol Genet</source>
            <year>2006</year>
            <month>Mar</month>
            <day>15</day>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>905</fpage>
            <page-range>905-19</page-range>
            <pub-id pub-id-type="pmid">16449236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Hauwere</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Leroy</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Adriaenssens</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Van Heule</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Iris dysplasia, orbital hypertelorism, and psychomotor retardation: a dominantly inherited developmental syndrome.</article-title>
            <source>J Pediatr</source>
            <year>1973</year>
            <month>Apr</month>
            <volume>82</volume>
            <issue>4</issue>
            <fpage>679</fpage>
            <page-range>679-81</page-range>
            <pub-id pub-id-type="pmid">4633364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowry</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Absence of PITX2, BARX1, and FOXC1 mutations in De Hauwere syndrome (Axenfeld-Rieger anomaly, hydrocephaly, hearing loss): a 25-year follow up.</article-title>
            <source>Am J Med Genet A</source>
            <year>2007</year>
            <month>Jun</month>
            <day>01</day>
            <volume>143A</volume>
            <issue>11</issue>
            <fpage>1227</fpage>
            <page-range>1227-30</page-range>
            <pub-id pub-id-type="pmid">17486624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badnaware</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Chandel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fulzele</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dental and Craniofacial Manifestation of Axenfeld-Rieger Syndrome: A Case Report.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>e26442</fpage>
            <pub-id pub-id-type="pmid">35923678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Idrees</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vaideanu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Sowden</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>A review of anterior segment dysgeneses.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2006</year>
            <season>May-Jun</season>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-31</page-range>
            <pub-id pub-id-type="pmid">16644364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Klintworth</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Thresher</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger syndrome. A spectrum of developmental disorders.</article-title>
            <source>Surv Ophthalmol</source>
            <year>1985</year>
            <season>May-Jun</season>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>387</fpage>
            <page-range>387-409</page-range>
            <pub-id pub-id-type="pmid">3892740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Iridocorneal Dysgenesis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">36251848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Churchill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genetics of aniridia and anterior segment dysgenesis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>80</volume>
            <issue>7</issue>
            <fpage>669</fpage>
            <page-range>669-73</page-range>
            <pub-id pub-id-type="pmid">8795384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alwadani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alward</surname>
                <given-names>WLM</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Bouhenni</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Brownstein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edward</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Posterior Embryotoxon Revisited: An Immunohistologic Study.</article-title>
            <source>Ophthalmol Glaucoma</source>
            <year>2022</year>
            <season>Jul-Aug</season>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>396</fpage>
            <page-range>396-401</page-range>
            <pub-id pub-id-type="pmid">35131519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delahaye</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khung-Savatovsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aboura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guimiot</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Drunat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alessandri</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>G&#x000e9;rard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bitoun</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boumendil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guilherme</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Serero</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gressens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Elion</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Verloes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benzacken</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Delezoide</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pipiras</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pre- and postnatal phenotype of 6p25 deletions involving the FOXC1 gene.</article-title>
            <source>Am J Med Genet A</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>158A</volume>
            <issue>10</issue>
            <fpage>2430</fpage>
            <page-range>2430-8</page-range>
            <pub-id pub-id-type="pmid">22903608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger and iridocorneal endothelial syndromes: two spectra of disease with striking similarities and differences.</article-title>
            <source>J Glaucoma</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>5 Suppl 1</issue>
            <fpage>S36</fpage>
            <page-range>S36-8</page-range>
            <pub-id pub-id-type="pmid">11890271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strungaru</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Dinu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>228</fpage>
            <page-range>228-37</page-range>
            <pub-id pub-id-type="pmid">17197537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Pehere</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Early-onset glaucoma in Axenfeld-Rieger anomaly: long-term surgical results and visual outcome.</article-title>
            <source>Eye (Lond)</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>936</fpage>
            <page-range>936-42</page-range>
            <pub-id pub-id-type="pmid">27055677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Anninger</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Piccoli</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Anterior Chamber Pathology in Alagille Syndrome.</article-title>
            <source>Ocul Oncol Pathol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>270</fpage>
            <page-range>270-275</page-range>
            <pub-id pub-id-type="pmid">27843908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rennie</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rajan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Vivian</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>The prevalence and associated features of posterior embryotoxon in the general ophthalmic clinic.</article-title>
            <source>Eye (Lond)</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>396</fpage>
            <page-range>396-9</page-range>
            <pub-id pub-id-type="pmid">15309023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reis</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Maheshwari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Capasso</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Atilla</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dudakova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zitano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lay-Son</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lowry</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shue</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kremlikova Pourova</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vaneckova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Skalicka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jedlickova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trkova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bachman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Costakos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Liskova</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Semina</surname>
                <given-names>EV</given-names>
              </name>
            </person-group>
            <article-title>Axenfeld-Rieger syndrome: more than meets the eye.</article-title>
            <source>J Med Genet</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>368</fpage>
            <page-range>368-379</page-range>
            <pub-id pub-id-type="pmid">35882526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r30">
          <label>30</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Humphrey Visual Field</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">36256759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoyme</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Hudgins</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Terminal deletion of 6p results in a recognizable phenotype.</article-title>
            <source>Am J Med Genet A</source>
            <year>2005</year>
            <month>Jul</month>
            <day>15</day>
            <volume>136</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-8</page-range>
            <pub-id pub-id-type="pmid">15940702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kipp</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Childhood glaucoma.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-104</page-range>
            <pub-id pub-id-type="pmid">12713106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zepeda</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Branham</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moroi</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bohnsack</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Surgical outcomes of Glaucoma associated with Axenfeld-Rieger syndrome.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2020</year>
            <month>May</month>
            <day>01</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>172</fpage>
            <pub-id pub-id-type="pmid">32357855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nassiri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nouri-Mahdavi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Ahmed glaucoma valve in children: A review.</article-title>
            <source>Saudi J Ophthalmol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-27</page-range>
            <pub-id pub-id-type="pmid">23960945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Anterior segment optical coherence tomography of iridoschisis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Oct</month>
            <day>05</day>
            <volume>14</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34610957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r36">
          <label>36</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Jat</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Peters Anomaly</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35593847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r37">
          <label>37</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Salini</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Aniridia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">30844160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r38">
          <label>38</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sridhar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Iris Ectropion Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35593818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pushker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Phthisis Bulbi-a Clinicopathological Perspective.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2018</year>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>788</fpage>
            <page-range>788-803</page-range>
            <pub-id pub-id-type="pmid">29902388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medina-Trillo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aroca-Aguilar</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Ferre-Fern&#x000e1;ndez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Alexandre-Moreno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morales</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ndez-Hern&#x000e1;ndez</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Feijoo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Escribano</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Role of FOXC2 and PITX2 rare variants associated with mild functional alterations as modifier factors in congenital glaucoma.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>e0211029</fpage>
            <pub-id pub-id-type="pmid">30657791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35481.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Du</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XP</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A Novel Mutation of FOXC1 (R127L) in an Axenfeld-Rieger Syndrome Family with Glaucoma and Multiple Congenital Heart Diseases.</article-title>
            <source>Ophthalmic Genet</source>
            <year>2016</year>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-5</page-range>
            <pub-id pub-id-type="pmid">24914578</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
